Perrigo Picks At Industry Self-Regulation Group Measuring Flosser Market By Units, Not Sales
Appeals NAD Decision On Oral-B Marketer P&G’s Challenge Of Plackers ‘#1 Brand’ Claim
NAD says “equivalized” sales data Perrigo submitted to support claim didn’t provide an accurate measure of flosser product category; instead, “un-equivalized” data P&G submitted were accurate measure. Perrigo counters that the decision conflated separate product categories as well as dismissed appropriate data.
You may also be interested in...
NARB panel concluded #1 claims challenged by Oral-B floss products marketer P&G aren’t supported by acceptable evidence that the type of product the claim referenced – flossers – “is recognized as a consumer-relevant category."
Ranir has a portfolio of more than 300 oral care solutions including power toothbrushes and heads, whitening strips, manual toothbrushes, floss, dentures and travel kits that it provides to retailers and other distributors in more than 50 countries. Adding Ranir, says Perrigo CEO Murray Kessler, "illustrates a key component of our new strategy, accelerating growth by pursuing adjacent self-care categories."
“Nonprescription Drug Product with an Additional Condition” for OTC use proposed rule would add to drug firms’ workloads for some OTC switches. Along with NDAs, sponsors would need to show a DFl isn’t sufficient to ensure a consumer can appropriately self-select and use a drug OTC and how an “additional condition” system would work.